Table 4.
Microorganism | Dose | Effect | Ref. |
---|---|---|---|
Staphylococcus aureus (MRSA) | 100 μg/mL | Citral inhibited the biofilm formation of human severe pathogen MRSA without affecting the growth. | [7] |
25 μg/mL | The percentage of biofilm inhibition by a synergistic combination of citral + thymol was 91%, while 22% and 28% of biofilm inhibition were observed for individual application, respectively. | [74] | |
S. aureus DMST 4745 S. aureus |
0.25 µL/mL | S. aureus DMST 4745 was more susceptible than S. aureus clinical isolate to citral, showing biofilm reductions of 74.6 and 46.5%, respectively. | [48] |
C. sakazakii | 0.8 mg/mL | 1/2 MIC for 48 h decreased biofilm formation by 59.62%. | [55] |
225 μM | The biofilm formation was inhibited by 67.1%, 69.5%, and 70.1% at the tested concentration after treatment at 25 °C for 24, 48, and 72 h, respectively. | [75] |